The World Health Organisation (WHO) has endorsed a technology developed by Indian scientists to detect tuberculosis and multi-drug resistant TB in view of its high diagnostic accuracy, health ministry officials said on Thursday.
Read moreThe World Health Organisation (WHO) has endorsed a technology developed by Indian scientists to detect tuberculosis and multi-drug resistant TB in view of its high diagnostic accuracy, health ministry officials said on Thursday.
New Delhi, Jan 16 (PTI) The World Health Organisation (WHO) has endorsed a technology developed by Indian scientists to detect tuberculosis and multi-drug resistant TB in view of its high diagnostic accuracy, health ministry officials said on Thursday.
Indigenously developed point-of-care (POC) molecular diagnostic test validated through multicentric studies and found to be comparable with internationally approved molecular diagnostic test
In a significant development, WHO Global Tuberculosis Programme has included an Indian molecular assay as initial test for detecting the disease and for identifying resistant strains of the TB bacteria.
Read moreThe World Health Organisation has endorsed TrueNat, an indigenous molecular diagnostic tool for tuberculosis (TB) diagnosis. The disease remains a threat to public health and is the top infectious cause of death globally.
High diagnostic accuracy of Truenat as initial test to diagnose TB (i.e. replacing sputum smear microscopy) and to sequentially detect rifampicin resistance
Read more
Dr. Chandrashekhar Nair discussing Truelab TM the real time quantitative micro-PCR system which is battery operated and provides point-of-care PCR testing and molecular diagnosis to patients.
Highlights from our live demonstration of point-of-care hepatitis C and hepatitis B diagnostic tests.
The very successful Conference on Liver Disease in Africa (COLDA) took place on 6 - 8 September 2019 in Cairo, Egypt.
This video presents the FIND symposium on available diagnostic technologies for hepatitis B and hepatitis C that took place during the 2019 edition of the Conference on Liver Disease in Africa (COLDA). The symposium was an opportunity for participants to learn more about the importance of diagnostics and to get firsthand introductions to several point-of-care molecular diagnostics platforms. These platforms represent the latest in terms of nucleic acid amplification assays and allow for faster time-to-diagnosis.
KolKata Municipal Corporation (KMC)health department is set to clear doubts about dengue tests being done at its ward centres
Read more